PTPRC and B-cell non-Hodgkin lymphoma: To address this, we utilized histology and flow cytometry with antibodies against human CD45 (hCD45, a human pan-hematopoietic marker) to monitor contamination of B-cell lymphoma (Supplementary Fig. S5A and S5B).